Analytical Data
-
Gene name
PLUNC
- Application
-
Alternative Names
PLUNC；LUNX；NASG；PLUNC；BPI fold-containing family A member 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NP55
-
Expression Region
20-256aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSQFGGLPV PLDQTLPLNV NPALPLSPTG LAGSLTNALS NGLLSGGLLG ILENLPLLDI LKPGGGTSGG LLGGLLGKVT SVIPGLNNII DIKVTDPQLL ELGLVQSPDG HRLYVTIPLG IKLQVNTPLV GASLLRLAVK LDITAEILAV RDKQERIHLV LGDCTHSPGS LQISLLDGLG PLPIQGLLDS LTGILNKVLP ELVQGNVCPL VNEVLRGLDI TLVHDIVNML IHGLQFVIKV
-
Molecular Weight
27 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PLUNC (Palate, Lung, and Nasal epithelium-Associated) proteins are a family of secreted proteins that are predominantly expressed in the respiratory epithelium and play essential roles in innate immunity and the maintenance of epithelial homeostasis. Research into PLUNC proteins has gained traction due to their potential implications in respiratory health and disease, particularly in conditions such as asthma, chronic obstructive pulmonary disease (COPD), and infections. The unique structural features of PLUNC proteins, including their ability to interact with lipids and pathogens, suggest they may serve as antimicrobial agents and modulators of inflammation. Recent studies have focused on the functional characterization of PLUNC proteins, revealing their involvement in mucosal defense mechanisms and their regulatory effects on immune responses. The exploration of PLUNC as a therapeutic target or biomarker for respiratory diseases is an emerging area of interest. Furthermore, advancements in recombinant protein technology have enabled the production of PLUNC proteins for in-depth functional studies, paving the way for potential applications in diagnostics and therapeutics. Overall, the investigation of PLUNC proteins not only enhances our understanding of airway biology but also opens avenues for novel interventions in respiratory disorders.
